Importantly, mice receiving gapmer 14 had significantly smaller tumors at the end of the experiment (Figures 4G and 4H) and a lower estimation of tumor growth during the experiment (Figure S4E), demonstrating the anti-tumor efficacy of targeting FANCM with gapmer 14. This evidence concerns the gene FANCM and neoplasm.